Free Account Opening + AMC Free Demat
Loading...

Brooks Laboratories Limited Rights Issue (Brooks Laboratories Rights Issue 2023) Detail

August 7, 2023 - August 22, 2023
Brooks Laboratories Limited Logo

Incorporated in 2002, Brooks Laboratories Limited is engaged in the manufacturing and marketing of pharmaceuticals nationally as well as at the international level. The company has its own manufacturing facility located at Baddi, Himachal Pradesh.

A Research and Development driven Pharmaceutical manufacturing company proffering a variety of solutions to customers.

Brooks Laboratories is a Pharmaceutical Contract Research and Manufacturing Services entity. They offer a wide range of products specifically catering to the critical care segment in Parental Section. The offerings include Beta Lactam, Ampoules and Liquid vials, General Dry powder Injectables, Dry Syrups and Tablets.

Products range includes:

  • Liquid Injection
  • Dry Powder Injection
  • Tablets
  • Oral Suspension

With a motivated team of highly qualified professionals, the company is working to stabilize new molecules in niche segments, in order to offer stable latest products to the end customers.

Brooks Laboratories Rights Issue 2023 Detail

Issue Open August 7, 2023 - August 22, 2023
Security Name Brooks Laboratories Limited
Issue Size (Shares) 1,543,926
Issue Size (Amount) ₹11.58 Crores
Issue Price ₹75 per share
Face Value ₹10 per share
Listing At BSE, NSE
Terms of Payment

Full amount of Rs. 75 for rights equity shares has to be paid on application.

Entitlement 1 Rights Equity Share(s) for every 16 fully paid-up Equity Shares held on Record Date

Brooks Laboratories Rights Issue 2023 Issue Timetable

Last Date to buy sharesJuly 27, 2023
Record Date July 28, 2023
Credit of Rights Entitlements August 3, 2023
Bid/Offer Opens On August 7, 2023
Renunciation of Rights Entitlements August 17, 2023
Bid/Offer Closes On August 22, 2023
Deemed Date of Allotment August 29, 2023
Credit Date August 30, 2023
Listing Date September 1, 2023

Company Financials

Brooks Laboratories Rights Issue 2023 Financial Information (Restated Consolidated)
Period Ended31 Mar 202231 Mar 2023
Assets195.91109.60
Revenue91.9963.41
Profit After Tax-18.31-31.05
Net Worth
Reserves and Surplus
Total Borrowing
Amount in ₹ Crore

Objects of the Issue:

The company intends to utilize the net proceeds from the issue towards the funding of the following objects:

  1. Funding the working capital requirements of the company
  2. General Corporate Purposes

Brooks Laboratories Rights Issue 2023 Documents

Brooks Laboratories Rights Issue 2023 Rating

3
3.0
Rating:Rated 3.0 stars
Vote Here ...

Brooks Laboratories Rights Issue 2023 Reviews

Company Contact Information

Brooks Laboratories Limited
Vill.Kishanpura,
Nalagarh Road,
Baddi - 174101

Phone: +91-1795 - 236939
Email: investors@brookslabs.net
Website: https://www.brookslabs.net/

Brooks Laboratories Rights Issue 2023 Registrar

  1. Link Intime India Private Ltd
    Phone: +91-22-4918 6270
    Email: brooks.rights2023@linkintime.co.in
    Website: https://linkintime.co.in/initial_offer/public-issues.html

Brooks Laboratories Rights Issue 2023 Lead Manager(s)

Brooks Laboratories Rights Issue 2023 FAQs

The Brooks Laboratories Rights Issue 2023 opens on August 7, 2023, and closes on August 22, 2023.

Brooks Laboratories Rights Issue 2023 Schedule

Last Date for credit of Rights EntitlementsAugust 3, 2023
Last Date for renunciation of Rights EntitlementsAugust 17, 2023
Issue Opening DateAugust 7, 2023
Issue Closing DateAugust 22, 2023
Date of Allotment (on or about)August 29, 2023
Date of Credit (on or about)August 30, 2023
Date of Listing (on or about)September 1, 2023

Brooks Laboratories Rights Issue 2023 price is set at ₹75 per share per equity share.

The eligible shareholders are being offered 1 Rights Equity Share(s) for every 16 fully paid-up Equity Shares held on Record Date (July 28, 2023).

The record date for the Brooks Laboratories Rights Issue 2023 is July 28, 2023.

The issue size of Brooks Laboratories Rights Issue 2023 is of 1,543,926 equity shares at ₹75 per share aggregating upto ₹11.58 Crores.

The Letter of Offer for Brooks Laboratories Rights Issue 2023 can be download here.

You can apply for Brooks Laboratories Rights Issue 2023 in two ways:

  1. Net Banking (ASBA)
  2. Registrar's Website (R-WAP Facility)

Steps to apply for Brooks Laboratories Rights Issue 2023 using Net Banking (ASBA)

  1. Log in to the net banking account of your bank.
  2. Go to the 'IPO & Rights Issue' section.
  3. Check if the Brooks Laboratories Rights Issue 2023 available on the list.
  4. Click the Apply button next to the Brooks Laboratories Rights Issue 2023.
  5. Fill and check your information.
  6. Submit the application.

Note: Your bank may not offer this facility to certain rights issues. In that case, you may have to choose the option below.

Steps to apply for Brooks Laboratories Rights Issue 2023 using Registrar's website (R-WAP)

  1. Visit registrar's website
  2. Go to the 'Rights Issue' section
  3. Select Brooks Laboratories Rights Issue 2023 from the dropdown.
  4. Enter Demat Account Number.
  5. Fill the online application form.
  6. Validate and submit the application.

Compare rights issues with Brooks Laboratories Rights Issue 2023